The popular preparation was useless against Koronavirus

Complications and side effects: to what conclusions scientists came? 1 Clinical tests Rekombinantny interferon beta-1 did not show its clinical advantage on October 18 in The Lancet Respiratory Medicine results of double blind randomized placebo - controlled research of efficiency of an immunomodulator interferon beta 1a against Koronavirus were published. The international group of physicians led by experts from National institutes an allergy and infectious diseases National...